- £68.12bn
- £80.41bn
- £30.33bn
- 87
- 46
- 95
- 91
REG - GSK PLC - Statement: Zantac (ranitidine) litigation
AnnouncementREG - GSK PLC - Transfer of Treasury Shares
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Jemperli positive trial in endometrial cancer
AnnouncementREG - GSK PLC - EMA file accepted for momelotinib
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK Capital B.V. GSK PLC - Publication of Final Terms of EMTN Notes
AnnouncementREG - GSK PLC - GSK publishes provisional 2023 dividend dates
AnnouncementREG - GlaxoSK Capital PLC GSK PLC - Publication of Supplementary EMTN Prospectus
AnnouncementREG - GSK PLC - Blenrep US Update
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSK Capital PLC GSK PLC - Publication of EMTN Supplementary Prospectus
AnnouncementREG - GlaxoSK Capital PLC GSK PLC - Final results of outstanding Notes Tender Offer
AnnouncementREG - GSK PLC - Block listing Interim Review
AnnouncementREG - GlaxoSK Capital PLC GSK PLC - Interim results of outstanding Notes Tender Offer
AnnouncementREG - GSK PLC - GSK Update: Zejula 2L in US
AnnouncementREG - GSK PLC - Sanofi-GSK COVID booster vaccine approved by EU
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Block Listing Application
Announcement